hydroxychloroquine and leptin

hydroxychloroquine has been researched along with leptin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Brismar, K; Engvall, IL; Hafström, I; Tengstrand, B1
Bolce, R; Chernoff, D; Cruickshank, SE; Forslind, K; Geborek, P; Hambardzumyan, K; Petersson, IF; Saevarsdottir, S; Sasso, EH; van Vollenhoven, RF1
Abdel-Hamid, AAM; Firgany, AEL1
Bolce, RJ; Ernestam, S; Forslind, K; Hambardzumyan, K; Petersson, IF; Saevarsdottir, S; van Vollenhoven, RF; Wallman, JK1
Dobashi, H; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Miyagi, T; Miyatake, N; Mizusaki, M; Nakashima, S; Shimada, H; Sugihara, K; Ueeda, K; Wakiya, R1

Trials

2 trial(s) available for hydroxychloroquine and leptin

ArticleYear
Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.
    Arthritis research & therapy, 2010, Volume: 12, Issue:5

    Topics: Absorptiometry, Photon; Adiponectin; Adipose Tissue; Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Apolipoproteins; Arthritis, Rheumatoid; Body Composition; Bone Density; Bone Remodeling; Female; Humans; Hydroxychloroquine; Infliximab; Insulin-Like Growth Factor I; Leptin; Male; Methotrexate; Middle Aged; Radioimmunoassay; Sulfasalazine

2010
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
    Annals of the rheumatic diseases, 2015, Volume: 74, Issue:6

    Topics: Adipokines; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Chitinase-3-Like Protein 1; Disease Progression; Drug Therapy, Combination; Epidermal Growth Factor; Female; Foot Joints; Hand Joints; Humans; Hydroxychloroquine; Infliximab; Interleukin-6; Lectins; Leptin; Logistic Models; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Methotrexate; Multivariate Analysis; Prognosis; Radiography; Receptors, Tumor Necrosis Factor, Type I; Resistin; Serum Amyloid A Protein; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A

2015

Other Studies

3 other study(ies) available for hydroxychloroquine and leptin

ArticleYear
Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines.
    Acta histochemica, 2016, Volume: 118, Issue:6

    Topics: Adipokines; Animals; Diet, High-Fat; Endothelial Cells; Hydroxychloroquine; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Islets of Langerhans; Leptin; Male; Nicotinamide Phosphoribosyltransferase; Obesity; Rats, Sprague-Dawley

2016
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
    Arthritis & rheumatology (Hoboken, N.J.), 2017, Volume: 69, Issue:5

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chitinase-3-Like Protein 1; Decision Support Techniques; Drug Therapy, Combination; Epidermal Growth Factor; Female; Humans; Hydroxychloroquine; Infliximab; Interleukin-6; Leptin; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor, Type I; Resistin; Serum Amyloid A Protein; Severity of Illness Index; Sulfasalazine; Treatment Failure; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A

2017
Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
    Clinical rheumatology, 2022, Volume: 41, Issue:11

    Topics: Adipokines; Adiponectin; Adult; Antibodies, Antinuclear; Antirheumatic Agents; Atherosclerosis; Cytokines; Estrogens; Female; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Leptin; Lipids; Lupus Erythematosus, Systemic; Male; Middle Aged; Resistin; Tumor Necrosis Factor-alpha

2022